Dicot Pharma AB (FRA:KN0)

Market Cap	57.40M -49.8%
Revenue (ttm)	n/a
Net Income	-6.57M
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0107
Previous Close	0.0110
Day's Range	0.0107 - 0.0107
52-Week Range	0.0107 - 0.1100
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 7, 2026

About Dicot Pharma AB

Dicot Pharma AB engages in the development of pharmaceutical products in Sweden. It develops LIB-01 that is in Phase 2a clinical trial for the treatment of erectile dysfunction and under medical discovery for treating premature ejaculation. The company was formerly known as Dicot AB (publ) and changed its name to Dicot Pharma AB in May 2024. Dicot Pharma AB was incorporated in 2015 and is based in Uppsala, Sweden.

• Industry: Pharmaceutical Preparations
• Founded: 2015
• Employees: 4
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: KN0

Financial Performance

Financial numbers in SEK

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jul 17, 2026

Data Sources Report a data error